MET US S&P 500Russell 1000 Earnings call · transcribed from the recording
MetLife (MET) · Q3 2026 results and valuation
Share price: $102.94 · 2026-11-11
MetLife provides insurance, annuities, employee benefits, and asset management services. The company serves corporations, government entities, and individuals across markets in the United States, Asia, Latin America, Europe, and the Middle East. Source: 10-K annual report (2026-02-19)
Results Q3 2026 vs Q2 2026 · previous quarter · published 4 Nov 2026 and 6 Aug 2026
Net income up 225.7% on the previous quarter. Management sounded upbeat, in its script and in answers to analysts.
Only a basic analysis is available for this company at the moment.
1 · Numbers
+225.7%
Net income vs Q2 2026
Outlook given
Net income 2.40B vs 736.0M
Revenue +7.1%
Against the same quarter last year (Q3 2025) it is +167.5%, so it is not just seasonal.
2 · How management spoke
Upbeat
More upbeat than 70% of company calls
Answers to analysts: restrained, in line with the script.
Last call it was different: the answers were less upbeat than the script.
3 · What stood out
Key theme
MetLife's direct expense ratio was 11.9%, on track to beat its 12.1% full-year target.
Valuation
Is MetLife undervalued?
Reverse DCF on net income from the last full fiscal year (no meaningful free cash flow: a bank, insurer or a year of negative cash flow) (2025-12-31), grown for 10 years, discounted back, plus a terminal value. “Implied growth” is the rate the current price assumes.
At 3.9% growth a year (3-year revenue growth), the model's fair value is $75.42 a share — the stock trades 36% above it. Today's price assumes 8.1% growth a year.
Current price
$102.94
close of 2026-11-11
Market implies growth of iThe yearly free-cash-flow growth, for the next 10 years, that today’s share price already assumes. If you believe the company grows faster than this, the stock is cheap under this model; slower, and it is expensive.
+8.1% for 10 yrs
Fair value / share
$75.42
Buy below
$56.57
Price vs fair value
Overvalued 36%
Price vs buy-below price
Overvalued 82%
Read between the lines
-
Guidance
Given the strength of the business year to date and assuming normal VII in the fourth quarter, MetLife expects full year RAS adjusted earnings to finish slightly north of the midpoint...
-
Figure
Year-to-date, adjusted Earnings per share excluding notable items are up 22% with Adjusted Return on Equity above 17%.
-
Fading
Volume growth was broad-based, and MetLife continues to fund promising growth opportunities while returning excess capital to shareholders.
Source quote
“Volume growth was broad-based, and we continue to fund promising growth opportunities while returning excess capital to shareholders. Underwriting performance was strong. This is New Frontier in action, leveraging our scale, market-leading businesses and strategic diversification to generate durable growth and attractive...”
Tone
How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q3 2026. Ring: Q2 2026.
Script and answers carried a similar tone, so the script's message held up under questioning.
Sentences that drove the tone
“AMIA's continued expansion drove adjusted PFO growth of 14%, or 17%, on a constant currency basis, supported by strong sales momentum and solid renewal activity.”
“Our expense discipline, strong returns on new business, and improving capital efficiency are helping translate growth into higher returns and strong cash generation.”
“Our broad scope and leading positions mean we are not reliant on any single retirement market and were able to pivot to those opportunities that represent the highest and best...”
Full figures
USD · SEC EDGAR XBRL (10-Q, period end 2026-09-30)
| Metric | Q3 2026period end 2026-09-30 | Q2 2026period end 2026-06-30 | Change | Q3 2025 | YoY |
|---|---|---|---|---|---|
| Revenue | 20.52B | 19.15B | +7.1% | 17.36B | +18.2% |
| Operating income | 1.83B | 1.60B | +13.8% | 1.65B | +10.7% |
| Net income | 2.40B | 736.0M | +225.7% | 896.0M | +167.5% |
| EPS | 3.67 | 1.09 | +236.7% | 1.22 | +200.8% |
| P/E today 12.8 | 12.3 | 16.2 | −3.9 | 15.5 | −3.2 |
Topics
Most discussed now
- Variable investment income was a significant contributor this quarter, particularly through private equity and venture capital returns.
- It's helping us grow, improve customer experience, and operate with greater speed and precision, all while holding down MetLife's ratio...
- Underwriting margins, fees, and spread income generate durable earnings and recurring cash flow.
- They allow us to invest in growth, generate strong free cash flow, and return excess capital to shareholders, all while...
- MetLife is generating attractive returns, maintaining expense discipline, and deploying capital into opportunities that create long-term…
Faded since Q2 2026
- Fading This was an outstanding quarter and another clear demonstration of how MetLife's New Frontier strategy is working as intended and...
- Fading MetLife generated broad-based growth across the enterprise, delivered excellent underwriting results, maintained disciplined expense…
- Fading MetLife is always open to considering new capabilities or solutions if that makes sense.
- Fading MetLife has obviously good visibility in terms of what's happening.
Latest announcements
Official filings, newest first. Summaries are generated from each filing and its attachment; every figure is checked against the source.
- Results of operations; Regulation FD disclosure; Other events · SEC 8-K
- Regulation FD disclosure · SEC 8-K
The company filed a Regulation FD disclosure on September 24, 2026, regarding Item 7.01 and its status under the Securities Exchange Act of 1934.
- Other events · SEC 8-K
MetLife, Inc. declared various preferred stock dividends on August 17, 2026, including a quarterly dividend of $0.31471411 per share for Series A and $0.3515625 per depositary share for Series E.
- Results of operations; Regulation FD disclosure; Other events · SEC 8-K
MetLife reported net income of $705 million, up 1% year-over-year, and adjusted earnings of $1.6 billion, up 15% from the previous year.
- Regulation FD disclosure · SEC 8-K
The company filed a Regulation FD disclosure on June 29, 2026, regarding Item 7.01 and its status under the Securities Exchange Act of 1934.
- Shareholder vote results · SEC 8-K · routine
- Other events · SEC 8-K
MetLife, Inc. declared quarterly dividends of $0.31190376 for Series A, $0.3515625 for Series E depositary shares, and $0.296875 for Series F depositary shares on May 15, 2026.
- Results of operations; Regulation FD disclosure; Other events · SEC 8-K
MetLife reported net income of $1.1 billion, up 30% year over year, and adjusted earnings of $1.6 billion, up 18% compared to the first quarter of 2025.
Balance sheet & ownership
From SEC filings; short interest is FINRA data via Yahoo. Collected 2026-10-11.
Cash & runway
Cash & equivalents
$19.30B
2026-06-30
Short-term investments
$8.02B
total $27.32B
Implied runway
—
operating cash flow positive over the TTM window
Dilution
weighted-average basic shares, per quarter. Change: -4.2% YoY, -1.4% QoQ.
| Quarter | Shares |
|---|---|
| Q3 2024 | 699.3M |
| Q1 2025 | 682.3M |
| Q2 2025 | 670.8M |
| Q3 2025 | 664.7M |
| Q1 2026 | 652.0M |
| Q2 2026 | 642.6M |
Shares outstanding: 635.5M (2026-07-31)
Insider transactions
Form 4 open-market trades (codes S/P), trailing 12 months. Coverage: newest 50 of 99 filings; 50 filings parsed.
Sold by insiders
21.3K shares
$1.7M · 1 transactions
Bought by insiders
0 shares
0 transactions
Net direction
net selling
Catalyst calendar
management-stated targets — from the latest earnings call; plans, not promises.
-
2026
annual target for direct expense ratio
Source quote
“Our direct expense ratio was 12.1% and keeping us on track to beat our 12.1% 2026 annual target.”
-
2026
target range for Group Life mortality ratio
Source quote
“The Group Life mortality ratio was 79% for the quarter, better than our 2026 target range of 83% to 88%, reflecting continued favorable mortality trends among the working age population.”
-
2026
outlook range for Retained liability exposures
Source quote
“Retained liability exposures grew 3% year-over-year at the low end of our 2026 outlook range, consistent with our expectation that growth would build over the year.”
-
first half of 2026
lighter PRT market
Source quote
“Importantly, even with a lighter PRT market in the first half of 2026, the team has continued to advance other sources of growth across the platform.”
-
the second half of the year
adjusted earnings to maintain their upward trajectory
Source quote
“And as integration benefits continue to emerge, we expect adjusted earnings to maintain their upward trajectory through the second half of the year.”